AK
Anil Kumar Jagirdar
About Anil Kumar Jagirdar
Data last updated:
Anil Kumar Jagirdar is a Nominee Director at Sunways (India) Private Limited (since 2024), Nominee Director at Pregna International Limited (since 2023) and Nominee Director at Abi-Health Technologies Private Limited (since 2023), and holds 3 more current directorships. The companies operate in Pharma, Healthcare and Information Technology. The 4 current companies with reported revenue have a combined latest revenue of ₹246 Cr; the largest is Sunways (India) Private Limited at ₹143 Cr (FY 2024). Earlier, Anil Kumar Jagirdar was a Director at Suryateja Healthcare Private Limited (2021) and Director at Rajyalakshmi Healthcare Private Limited (2021) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Nominee Director | 05 Sep 2024 | 1990 | ₹143 Cr (FY 2024) | Active | |
| Nominee Director | 05 Jul 2023 | 1993 | ₹58.91 Cr (FY 2024) | Active | |
| Nominee Director | 19 Dec 2023 | 2008 | ₹28.07 Cr (FY 2025) | Active | |
| Nominee Director | 30 Sep 2024 | 1986 | ₹16.12 Cr (FY 2025) | Active | |
| Designated Partner | 01 Nov 2024 | 2022 | Active | ||
| Partner | 12 Jul 2023 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Jun 2021 | 2014 | ₹14.87 Cr (FY 2025) | Active | |
| Director | 01 Jun 2021 | 2015 | ₹157 Cr (FY 2024) | Amalgamated | |
| Director | 01 Jun 2021 | 2008 | ₹600 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anil Kumar Jagirdar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anil Kumar Jagirdar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anil Kumar Jagirdar
Anil Kumar Jagirdar currently holds 6 directorships: Sunways (India) Private Limited (Nominee Director, since 05 Sep 2024, revenue ₹143 Cr (FY 2024)); Pregna International Limited (Nominee Director, since 05 Jul 2023, revenue ₹58.91 Cr (FY 2024)); Abi-Health Technologies Private Limited (Nominee Director, since 19 Dec 2023, revenue ₹28.07 Cr (FY 2025)); Sunways Rohto Pharmaceutical Private Limited (Nominee Director, since 30 Sep 2024, revenue ₹16.12 Cr (FY 2025)); Ilsf Lifesciences Manager Llp (Designated Partner, since 01 Nov 2024); and 1 more.
Anil Kumar Jagirdar was first appointed on 01 Jun 2021 as Director at Suryateja Healthcare Private Limited. The most recent appointment on record is 01 Nov 2024 at Ilsf Lifesciences Manager Llp.
The 4 current companies of Anil Kumar Jagirdar that report revenue have a combined latest revenue of ₹246 Cr: Sunways (India) Private Limited ₹143 Cr (FY 2024); Pregna International Limited ₹58.91 Cr (FY 2024); Abi-Health Technologies Private Limited ₹28.07 Cr (FY 2025); Sunways Rohto Pharmaceutical Private Limited ₹16.12 Cr (FY 2025).
Anil Kumar Jagirdar held 3 earlier board appointments: Suryateja Healthcare Private Limited (Director, 01 Jun 2021 to 08 Jul 2021); Rajyalakshmi Healthcare Private Limited (Director, 01 Jun 2021 to 08 Jul 2021); Sarvejana Healthcare Private Limited (Director, 01 Jun 2021 to 08 Jul 2021).
The current boards of Anil Kumar Jagirdar's companies include Aatish Anupam Shroff (Sunways (India) Private Limited), Anupam Kantilal Shroff (Sunways (India) Private Limited), Bhadresh Kantilal Shroff (Sunways (India) Private Limited), Firaq Pankaj Shroff (Sunways (India) Private Limited), Ratheen Bhadresh Shroff (Sunways (India) Private Limited), Jaiprakash Taparia (Pregna International Limited), among others.